← SynDRA
BIRABRESIB
SynDRA canonical compound SYN0038318 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | BRD2 | BRD3 | BRD4 | SELE | VCAM1 |
| Mechanism of action | bromodomain inhibitor |
All known targets
- BRD2
- BRD4
- BRD3
- BRDT
- SELE
- VCAM1
Mechanisms of action (all sources)
- BRD2 INHIBITOR
- Bromodomain and extra-terminal motif (BET) inhibitor
- BET bromodomain inhibitor
- BRDT INHIBITOR
- BRD3 INHIBITOR
- BRD4 MODULATOR
- BRD2 MODULATOR
Cross-references
Synonyms
- Y-803 anhydrous
- MK-8628
- OTX-015
- OTX-015 ANHYDROUS
- OTX015
- OTX015 ANHYDROUS
- MK 8628
- OTX 015
- OTX-015 anhydrous
- Birabresib [USAN]
- X40LKS49S3
- (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide
- 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-
- OTX015 pound MK 8628/Birabresib pound(c)
- (S)-2-(4-(4-Chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]-triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetaMide
- 6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-
- (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide.
- 2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide
- 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]-N-(4-hydroxyphenyl)acetamide
- UNII-X40LKS49S3
- MK-8628;Birabresib
- OTX015 (Birabresib)
- BIRABRESIB [INN]
- Birabresib (USAN/INN)
- BIRABRESIB [WHO-DD]
- GTPL8359
- SCHEMBL2898131
- CHEMBL3581647
- EX-A640
- CHEBI:191051
- DTXSID701103937
- ZINC3960759
- BDBM50092312
- MFCD26960949
- NSC778747
- s7360
- AKOS027323345
- CCG-264724
Look up BIRABRESIB in the interactive SynDRA portal →